Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis

被引：3
|
作者：
Napolitano, Maddalena [1 ]
Gallo, Lucia [2 ]
Megna, Matteo [2 ]
Fabbrocini, Gabriella [2 ]
Nocerino, Mariateresa [2 ]
Abategiovanni, Luisa [2 ]
Patruno, Cataldo [3 ]
机构：
[1] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[2] Univ Naples Federico II, Sect Dermatol, Dept Clin Med & Surg, Naples, Italy
[3] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy
来源：
DERMATOLOGIC THERAPY | 2019年 / 32卷 / 03期
关键词：
certolizumab; hypersensitivity reaction; monoclonal antibodies;
D O I：
10.1111/dth.12900
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The pathogenic mechanism of hypersensitivity reactions (HSRs) to monoclonal antibodies is not fully understood. HSRs can occur after the first exposure or multiple exposures and include acute infusion reactions induced by cytokine release, besides Type I, Type III, and Type IV reactions.). We reported a case of anaphylactic reaction to certolizumab pegol in a patient affected by psoriatic arthritis and a possible management of this condition.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DELAYED CUTANEOUS HYPERSENSITIVITY REACTION TO CERTOLIZUMAB PEGOL IN A PATIENT WITH RHEUMATOID ARTHRITIS
    Iammatteo, M.
    Lowes, M.
    Broder, A.
    Jovanovic, B.
    Sarwar, U.
    Jacobson, M.
    Jerschow, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A46 - A47
  • [2] Certolizumab Pegol and Psoriatic Arthritis
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (01) : 128 - 129
  • [3] Certolizumab pegol for the treatment of psoriatic arthritis
    Hansen, Renata Baronaite
    Kavanaugh, Arthur
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (03) : 307 - 318
  • [4] Certolizumab Pegol for Psoriasis and Psoriatic Arthritis
    Reddy, Vidhatha
    Thibodeaux, Quinn
    Koo, John
    [J]. CURRENT DERMATOLOGY REPORTS, 2020, 9 (02) : 100 - 106
  • [5] Certolizumab Pegol for Psoriasis and Psoriatic Arthritis
    Vidhatha Reddy
    Quinn Thibodeaux
    John Koo
    [J]. Current Dermatology Reports, 2020, 9 : 100 - 106
  • [6] CERTOLIZUMAB PEGOL CHALLENGE FOR TREATMENT OF PSORIASIS IN A PATIENT WITH HYPERSENSITIVITY REACTION TO INFLIXIMAB
    Luu, J.
    Noh, J.
    Belkin, L. Presser
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S98 - S98
  • [7] Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis
    Esposito, Maria
    Carubbi, Francesco
    Giunta, Alessandro
    Alunno, Alessia
    Giacomelli, Roberto
    Fargnoli, Maria Concetta
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (02) : 119 - 128
  • [8] Certolizumab Pegol (Cimzia) and Ustekinumab (Stelara) for Psoriatic Arthritis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1435): : 10 - 12
  • [9] Efficacy of certolizumab pegol in naive versus multi-treated patients affected by psoriatic arthritis
    Dattola, Annunziata
    Vollono, Laura
    Cannizzaro, Maria, V
    Caro, Raffaele D. Caposiena
    Mazzilli, Sara
    Melino, Gennaro
    Candi, Eleonora
    Campione, Elena
    Bianchi, Luca
    [J]. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (04) : 434 - 439
  • [10] Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis
    Hum, Ryan M.
    Kanigicherla, Durga A.
    Ho, Pauline
    [J]. OXFORD MEDICAL CASE REPORTS, 2022, 2022 (12): : 414 - 416
12345